Koch Industries Inc Glaukos Corp Transaction History

Koch Industries Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$27.62 - $44.51 $279,348 - $450,174	-10,114 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$26.05 - $34.5 $197,875 - $262,062	-7,596 Reduced 42.89%	10,114 $312,000
Q4 2017 Feb 13, 2018	BUY	$24.5 - $36.01 $260,606 - $383,038	10,637 Added 150.39%	17,710 $454,000
Q3 2017 Nov 13, 2017	SELL	$31.26 - $42.03 $293,687 - $394,871	-9,395 Reduced 57.05%	7,073 $234,000
Q2 2017 Aug 16, 2017	SELL	N/A	-682,927 Reduced 97.65%	16,468 $683,000
Q2 2017 Aug 15, 2017	BUY	N/A	699,395	699,395 $683,000

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.2B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Koch Industries Inc, based on Form 13F filings with the SEC.

Stay updated on Koch Industries Inc with notifications on news.